Published online 23 February 2004. doi:10.1083/jcb.200312028
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 164, Number 5, 689-699
Regulation of RasMAPK pathway mitogenic activity by restricting nuclear entry of activated MAPK in endoderm differentiation of embryonic carcinoma and stem cells
Elizabeth R. Smith,
Jennifer L. Smedberg,
Malgorzata E. Rula, and
Xiang-Xi Xu
Ovarian Cancer and Tumor Cell Biology Programs, Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111
Address correspondence to Xiang-Xi Xu, Ovarian Cancer and Tumor Cell Biology Programs, Dept. of Medical Oncology, Medical Science Division, Fox Chase Cancer Center, 7701 Burholme Ave., Philadelphia, PA 19111. Tel.: (215) 728-2188. Fax: (215) 728-2741. email: X_Xu{at}fccc.edu
In response to retinoic acid, embryonic stem and carcinoma cells undergo differentiation to embryonic primitive endoderm cells, accompanied by a reduction in cell proliferation. Differentiation does not reduce the activation of cellular MAPK/Erk, but does uncouple mitogen-activated protein kinase (MAPK) activation from phosphorylation/activation of Elk-1 and results in inhibition of c-Fos expression, whereas phosphorylation of the cytoplasmic substrate p90RSK remains unaltered. Cell fractionation and confocal immunofluorescence microscopy demonstrated that activated MAPK is restricted to the cytoplasmic compartment after differentiation. An intact actin and microtubule cytoskeleton appears to be required for the restriction of MAPK nuclear entry induced by retinoic acid treatment because the cytoskeletal disrupting agents nocodazole, colchicine, and cytochalasin D are able to revert the suppression of c-Fos expression. Thus, suppression of cell proliferation after retinoic acidinduced endoderm differentiation of embryonic stem and carcinoma cells is achieved by restricting nuclear entry of activated MAPK, and an intact cytoskeleton is required for the restraint.
Key Words: retinoic acid; c-Fos; Elk-1; cytoskeleton; nucleocytoplasmic translocation
Abbreviations used in this paper: EC, embryonic carcinoma; Erk, extracellular signalregulated kinase; ES, embryonic stem; LIF, leukocyte inhibitory factor; MEK, MAPK kinase; pErk, phosphorylated MAPK/Erk; PI, propidium iodide; RA, retinoic acid.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Related Article
-
The nucleus shuns MAPK
- Nicole LeBrasseur
J. Cell Biol. 2004 164: 633.
[Full Text]
[PDF]
This article has been cited by other articles:
-
Masaki, H., Nishida, T., Kitajima, S., Asahina, K., Teraoka, H.
(2007). Developmental Pluripotency-associated 4 (DPPA4) Localized in Active Chromatin Inhibits Mouse Embryonic Stem Cell Differentiation into a Primitive Ectoderm Lineage. J. Biol. Chem.
282: 33034-33042
[Abstract]
[Full Text]
-
James, B. P., Bunch, T. A., Krishnamoorthy, S., Perkins, L. A., Brower, D. L.
(2007). Nuclear Localization of the ERK MAP Kinase Mediated by Drosophila {alpha}PS2betaPS Integrin and Importin-7. Mol. Biol. Cell
18: 4190-4199
[Abstract]
[Full Text]
-
Rozenfeld, R., Devi, L. A.
(2007). Receptor heterodimerization leads to a switch in signaling: {beta}-arrestin2-mediated ERK activation by {micro}-{delta} opioid receptor heterodimers. FASEB J.
21: 2455-2465
[Abstract]
[Full Text]
-
Khan, A. M., Ponzio, T. A., Sanchez-Watts, G., Stanley, B. G., Hatton, G. I., Watts, A. G.
(2007). Catecholaminergic Control of Mitogen-Activated Protein Kinase Signaling in Paraventricular Neuroendocrine Neurons In Vivo and In Vitro: A Proposed Role during Glycemic Challenges. J. Neurosci.
27: 7344-7360
[Abstract]
[Full Text]
-
Ebner, H. L., Blatzer, M., Nawaz, M., Krumschnabel, G.
(2007). Activation and nuclear translocation of ERK in response to ligand-dependent and -independent stimuli in liver and gill cells from rainbow trout. J. Exp. Biol.
210: 1036-1045
[Abstract]
[Full Text]
-
Kim, E., Clark, A. L., Kiss, A., Hahn, J. W., Wesselschmidt, R., Coscia, C. J., Belcheva, M. M.
(2006). {micro}- and {kappa}-Opioids Induce the Differentiation of Embryonic Stem Cells to Neural Progenitors. J. Biol. Chem.
281: 33749-33760
[Abstract]
[Full Text]
-
Day, R. M., Lee, Y. H., Park, A.-M., Suzuki, Y. J.
(2006). Retinoic Acid Inhibits Airway Smooth Muscle Cell Migration. Am. J. Respir. Cell Mol. Bio.
34: 695-703
[Abstract]
[Full Text]
-
Vrailas, A. D., Marenda, D. R., Cook, S. E., Powers, M. A., Lorenzen, J. A., Perkins, L. A., Moses, K.
(2006). smoothened and thickveins regulate Moleskin/Importin 7-mediated MAP kinase signaling in the developing Drosophila eye. Development
133: 1485-1494
[Abstract]
[Full Text]
-
Nur-E-Kamal, A., Ahmed, I., Kamal, J., Schindler, M., Meiners, S.
(2006). Three-Dimensional Nanofibrillar Surfaces Promote Self-Renewal in Mouse Embryonic Stem Cells. Stem Cells
24: 426-433
[Abstract]
[Full Text]
-
Zhao, M., DiScipio, R. G., Wimmer, A. G., Schraufstatter, I. U.
(2006). Regulation of CXCR4-Mediated Nuclear Translocation of Extracellular Signal-Related Kinases 1 and 2. Mol. Pharmacol.
69: 66-75
[Abstract]
[Full Text]
-
Marenda, D. R., Vrailas, A. D., Rodrigues, A. B., Cook, S., Powers, M. A., Lorenzen, J. A., Perkins, L. A., Moses, K.
(2006). MAP kinase subcellular localization controls both pattern and proliferation in the developing Drosophila wing. Development
133: 43-51
[Abstract]
[Full Text]
-
Ebisuya, M., Kondoh, K., Nishida, E.
(2005). The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity. J. Cell Sci.
118: 2997-3002
[Abstract]
[Full Text]
-
Plotkin, L. I., Aguirre, J. I., Kousteni, S., Manolagas, S. C., Bellido, T.
(2005). Bisphosphonates and Estrogens Inhibit Osteocyte Apoptosis via Distinct Molecular Mechanisms Downstream of Extracellular Signal-regulated Kinase Activation. J. Biol. Chem.
280: 7317-7325
[Abstract]
[Full Text]
-
Subauste, M. C., Pertz, O., Adamson, E. D., Turner, C. E., Junger, S., Hahn, K. M.
(2004). Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility. J. Cell Biol.
165: 371-381
[Abstract]
[Full Text]